Antibiotic resistance is becoming increasingly widespread, underlining the importance of rapid, accurate identification of bacterial infections for effective diagnostic, clinical, and environmental management. While next-generation sequencing excels at genetic characterization, it falls short in real-time, in situ detection, a critical gap where nucleic acid aptamers emerge as a compelling alternative. These synthetic oligonucleotides enable direct, low-cost, and versatile detection of bacterial targets without requiring DNA extraction or amplification. Their portability supports point-of-care diagnostics, while their molecular precision enables integration into advanced bioimaging platforms for non-invasive, real-time, spatial, and functional monitoring of pathogens in biological environments. This perspective explores the potential of aptamers for bacterial bioimaging, assessing the landscape of bacterial-targeting aptamers, zooming in on aptamer-based bioimaging approaches for bacterial detection, addressing key challenges, and outlining future opportunities, such as real-time dynamic infection imaging and theranostics, polyclonal/multivalent aptamers, multiplex imaging, aptamer-based biosensors, and AI-driven detection.
No takes yet. Share an insight, caveat, or question.
Mezouarhi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: